COMP <GO>
CLBT vs MSFT // EV/EBITDA & P/E VALUATION
Cellebrite DI Ltd. (NASDAQ) VS. Microsoft Corporation (NASDAQ) • 15-METRIC TALLY: CLBT 4
— MSFT 9
▲ EV/EBITDA & P/E VALUATION LEADER: MSFT
LAST: $12.28 (+3.02%) • MKT CAP: $3.09B
valuation
38.1x
LAST: $530.14 (-0.16%) • MKT CAP: $3.94T
valuation
19.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLBT VS. MSFT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLBT | MSFT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 84.20% | 67.66% | +16.54 | CLBT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.60% | 26.54% | -11.94 | MSFT | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 38.1x | 19.9x | +18.17 | MSFT | /valuation <GO> |
| Free Cash Flow Yield | 5.19% | 1.55% | +3.64 | CLBT | /fcf-yield <GO> |
| Operating Margin | 14.00% | 47.10% | -33.10 | MSFT | /operating-margins <GO> |
| Net Profit Margin | 16.50% | 41.17% | -24.67 | MSFT | /net-margins <GO> |
| Revenue Growth (YoY) | 18.60% | 17.91% | +0.69 | CLBT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.70% | -0.70 | MSFT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.95 | 9.35 | -4.40 | MSFT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | CLBT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 5.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.1 | 64.8 | -6.68 | MSFT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.14 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.1x | 24.2x | +8.91 | MSFT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.09B | $3.94T | -$3.93T | MSFT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLBT REV | MSFT REV | CLBT GROSS % | MSFT GROSS % | CLBT FCF | MSFT FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $331.84B | — | 67.9% | — | $66.99B |
| FY 2025 | $475.7M | $281.72B | 84.2% | 68.8% | $160.3M | $71.61B |
| FY 2024 | $401.2M | $245.12B | 84.4% | 69.8% | $123.6M | $74.07B |
| FY 2023 | $325.1M | $211.91B | — | 68.9% | $102.1M | $59.48B |
| FY 2022 | — | $198.27B | — | 68.4% | — | $65.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLBT // BETA —
MSFT // BETA 1.14